The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
The science of puromycin: From studies of ribosome function to applications in biotechnology
Open accessAbstract
Puromycin is a naturally occurring aminonucleoside antibiotic that inhibits protein synthesis by ribosome-catalyzed incorporation into the C-terminus of elongating nascent chains, blocking further extension and resulting in premature termination of translation. It is most commonly known as a selection marker for cell lines genetically engineered to express a resistance transgene, but its additional uses as a probe for protein synthesis have proven invaluable across a wide variety of model systems, ranging from purified ribosomes and cell-free translation to intact cultured cells and whole animals. Puromycin is comprised of a nucleoside covalently bound to an amino acid, mimicking the 3' end of aminoacylated tRNAs that participate in delivery of amino acids to elongating ribosomes. Both moieties can tolerate some chemical substitutions and modifications without significant loss of activity, generating a diverse toolbox of puromycin-based reagents with added functionality, such as biotin for affinity purification or fluorophores for fluorescent microscopy detection. These reagents, as well as anti-puromycin antibodies, have played a pivotal role in advancing our understanding of the regulation and dysregulation of protein synthesis in normal and pathological processes, including immune response and neurological function. This manuscript reviews the current state of puromycin-based research, including structure and mechanism of action, relevant derivatives, use in advanced methodologies and some of the major insights generated using such techniques both in the lab and the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haematopoietic stem cells require a highly regulated protein synthesis rate
Signer, R. A. J., Magee, J. A., Salic, A., & Morrison, S. J. (2014) · Nature · doi:10.1038/nature13035 · Cited by 674
Global analysis of cellular protein translation by pulsed SILAC
Schwanhäusser, B., Gossen, M., Dittmar, G., & Selbach, M. (2009) · PROTEOMICS · doi:10.1002/pmic.200800275 · Cited by 356 · cited 1×
“[44,47] AA isotopes (pSILAC) [59] Click-”
Meier, S., Bell, M., Lyons, D. N., Rodriguez-Rivera, J., Ingram, A., Fontaine, S. N., Mechas, E., Chen, J., Wolozin, B., LeVine, H., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3029-15.2016 · Cited by 190
Tau drives translational selectivity by interacting with ribosomal proteins
Koren, S. A., Hamm, M. J., Meier, S. E., Weiss, B. E., Nation, G. K., Chishti, E. A., Arango, J. P., Chen, J., Zhu, H., Blalock, E. M., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01970-9 · Cited by 122
Target-Binding Proteins Based on the 10th Human Fibronectin Type III Domain (10Fn3)
Koide, S., Koide, A., & Lipovšek, D. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-396962-0.00006-9 · Cited by 84
Cited by
Argüello, R. J., Combes, A. J., Char, R., Gigan, J.-P., Baaziz, A. I., Bousiquot, E., Camosseto, V., Samad, B., Tsui, J., Yan, P., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.007 · Cited by 577
Circadian regulation of macromolecular complex turnover and proteome renewal
(2024) · doi:10.1038/s44318-024-00121-5 · Cited by 24
pSNAP: Proteome-wide analysis of elongating nascent polypeptide chains
Uchiyama, J., Roy, R., Wang, D. O., Morikawa, K., Kawahara, Y., Iwasaki, M., Yoshino, C., Mishima, Y., Ishihama, Y., & Imami, K. (2022) · iScience · doi:10.1016/j.isci.2022.104516 · Cited by 12
Men, Y., Higashimori, H., Reynolds, K., Tu, L., Jarvis, R., & Yang, Y. (2022) · The Journal of Neuroscience · doi:10.1523/jneurosci.0274-22.2022 · Cited by 7
Metadata
- Authors
- Aviner, R.
- Venue
- Computational and Structural Biotechnology Journal
- Published
- 2020
- Volume
- 18
- Pages
- 1074-1083
- ISSN
- 2001-0370 (ISSN-L)
- OpenAlex
- W3019545037
- Cited by
- 214
- References
- 5
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.